Table 1 Indications for SEMS placement
From: An outcome analysis of self-expandable metallic stents in central airway obstruction: a cohort study
Conditions | Number of patients | Number of SEMSs |
|---|---|---|
Malignant diseases | ||
   Primary lung cancer with airway invasion | ||
NSCLC | 35(45.4) | 45(47.3) |
SCLC | 7(9.1) | 7(7.4) |
Carcinoid | 1(1.3) | 2(2.1) |
Sacrcoma | 1(1.3) | 1(1.1) |
   Oesophageal cancer | ||
TE fistula | 24(31.2) | 31(32.6) |
Tracheal stenosis for tumour invasion | 3(3.9) | 3(3.2) |
   Other malignancy with trachea invasion | 2(2.6) | 2(2.6) |
   Mediastinal mass compression | 4(5.2) | 4(5.2) |
   Subtotal | 77 | 95 |
Benign diseases | ||
   Malacia | 29(40.3) | 64(55.2) |
   Post-intubation stenosis | 9(12.5) | 11(9.5) |
   Post-TB stenosis | 9(12.5) | 11(9.5) |
   Granulation restenosis | 9(12.5) | 13(11.2) |
   Stent fracture | 6(8.3) | 6(5.2) |
   Goiter | 4(5.6) | 4(3.4) |
   Corrosive injury | 2(2.8) | 3(2.6) |
   Mediastinitis | 2(2.8) | 2(1.7) |
   Tracheitis | 2(2.8) | 2(1.7) |
   Subtotal | 72 | 116 |
Total | 149 | 211 |